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The TRIM24 gene is organized in 19 exons. There are 
2 corresponding transcripts, which give rise to 2 
different isoforms (alternative splicing), the first one 
being shorter. 
transcript = 3905 bp; protein = 1016 amino acids; 
transcript = 4007 bp; protein = 1050 amino acids. 
Protein 
Description 
TRIM24 encodes a nuclear protein, transcription 
intermediary factor 1a displaying an RBCC motif 
(RING finger, B-BOX, and coiled-coil domains, also 
called tripartite motif, TRIM) in its N-terminus and 
PHD and bromo domains at the C-terminus. The 
following is a scheme (not drawn to scale) of the 
protein and its domains. 
Expression 
Ubiquitously and early in development, but also in 
many adult tissues. 
Localisation 
The protein localizes to the nucleus (nuclear bodies). 
Function 
Transcriptional regulator of nuclear receptors, 
including retinoic acid, thyroid, vitamin D3, and 
estrogen receptors; participates in multiprotein 
complexes; interacts with numerous proteins involved 
in chromatin structure; recruitment of TRIM24 to 
specific sites in the genome would ensure the 
localization of initiating RNA polII, and of chromatin 
remodeling complexes; may function through 
modulation of chromatin states (regulator of higher 
order chromatin structures, in order to promote 
silencing on euchromatic genes); TRIM24 has been 
demonstrated to possess an intrinsic transcriptional 
silencing activity which requires histone deacetylation; 
interacts directly with members of the heterochromatin 
protein 1 family. May be a key regulator of 
developmental and physiological processes. 
Homology 
TRIM28/TIF1B, TRIM33/TIF1G, TRIM66/TIF1D. 
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Implicated in 
t(7;8)(q34;p11) in leukemia → TRIM24-
FGFR1 
Disease 
acute myeloid leukemia (AML), 8p11 






The 2 predicted fusion proteins are organized as 
follows: TRIM24-FGFR1 contains the RING, BBOX 
and BBC domains from TRIM24 and the TK domain 
from FGFR1; FGFR1-TRIM24 contains the signal 
peptide along with the 3 IG-LIKE and transmembrane 
domains from FGFR1 and the PHD with the BROMO 
domains from TRIM24. 
t(7;10)(q34;q11) in papillary thyroid 
carcinoma  → TRIM24-RET 
Disease 
Found in one case of papillary thyroid carcinoma, in a 
child (a boy aged 4 yrs) exposed to radioactive fallout 
after the Chernobyl reactor accident (note: children 
exposed to Chernobyl radioactive fallout frequently 
developped papillary thyroid carcinoma (PTC), and a 
very high prevalence of RET rearrangements was 
found in these childhood PTC, compared to PTC of 
adults). 
Abnormal Protein 
Fusion of the 5' end of TRIM24 including the RBCC 
(RING finger, B-BOX, and coiled-coil domains) motif 
to the 3' end of RET including the tyrosine kinase 
domain (and loosing the ligand binding and 
transmembrane domains of RET). 
Oncogenesis 
The fusion protein could form dimers (via the coiled 
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